You are here

patents

The end of the Humira era

EP Vantage

Mon, 01/30/23 - 10:46 am

In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'

Endpoints

Thu, 01/26/23 - 05:05 pm

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Tue, 01/24/23 - 06:31 pm

Bristol Myers Squibb

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Endpoints

Tue, 01/24/23 - 06:18 pm

multiple sclerosis

Masimo Takes a Bite Out of Apple

Medical Devices and Diagnostics Industry

Wed, 01/11/23 - 10:50 am

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Fierce Pharma

Thu, 01/5/23 - 05:00 pm

Astellas loses bid to block Lexiscan generics in US

Pharmaphorum

Wed, 01/4/23 - 05:15 pm

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support

Endpoints

Tue, 01/3/23 - 10:24 pm

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

Fierce Pharma

Fri, 12/16/22 - 11:08 am

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Endpoints

Thu, 12/15/22 - 11:04 pm

Court swats down Vanda's patent suit against Teva and Apotex, clearing the way for Hetlioz generics

Fierce Pharma

Wed, 12/14/22 - 07:37 pm

Vanda Pharmaceuticals

Teva Pharmaceutical

Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)

BioSpace

Tue, 12/13/22 - 10:27 am

Pfizer, BioNTech strike back at Moderna with mRNA vaccine patent lawsuit

Fierce Pharma

Tue, 12/6/22 - 08:52 pm

Moderna Therapeutics

In Face of Multiple Patent Cliffs, Novartis' Prostate Cancer Drug Shows Promise

BioSpace

Mon, 12/5/22 - 10:58 am

prostate cancer

clinical trials

Federal claims court rules in favor of Gilead in CDC Truvada patent case

Endpoints

Thu, 12/1/22 - 07:08 pm

Gilead Sciences

J&J sues Amgen over plan to sell drug similar to Stelara

Business Insurance

Thu, 12/1/22 - 10:48 am

ulcerative colitis

'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says

Fierce Pharma

Wed, 11/23/22 - 07:33 am

Bristol Myers Squibb

FTC Amicus Brief Challenges Abuse of FDA “Orange Book” Listing Procedures to Block Drug Competition

FTC

Sun, 11/13/22 - 06:56 pm

Jazz Pharmaceuticals

Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight

Fierce Pharma

Thu, 11/10/22 - 10:12 pm

Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron

Fierce Pharma

Mon, 11/7/22 - 10:55 am

Pages